The global Hydroxychloroquine Sulphate market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025.
This report focuses on Hydroxychloroquine Sulphate volume and value at global level, regional level and company level. From a global perspective, this report represents overall Hydroxychloroquine Sulphate market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Hydroxychloroquine Sulphate in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Hydroxychloroquine Sulphate manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
Sanofi
H-QYN
Mylan
TAJ Pharma
Maan Medex Private Limited
Cinkate
Concordia Healthcare
Shanghai Zhongxisanwei
Shenhua Pharm
Wuhan Wuyao Pharmaceutial

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
100mg Hydroxychloroquine Sulphate
200mg Hydroxychloroquine Sulphate

Segment by Application
Discoid Lupus Erythematosus
Systemic Lupus Erythematosus
Other